Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
rhGH in Shock Phase of Severe Burns
ChiCTR-IPR-16008063Phase 4Recruiting
- Sponsor
- Central Hospital Affiliated to Shandong First Medical University
- Start
- Jan 2016
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 4 trial of somatropin in burn injury (2 arms), sponsored by Central Hospital Affiliated to Shandong First Medical University. Primary endpoints: Growth hormone mRNA in peripheral blood cells, Serum growth hormone level and 21 more. Started Jan 2016; status: recruiting.
02
Drugs
somatropin
03
Conditions
burn injury
Beyond the preview
Go deeper on ChiCTR-IPR-16008063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-IPR-16008063.